Akebia Therapeutics Inc

Akebia Therapeutics Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company employs 321 people and generated $223 million in revenue. Akebia Therapeutics focuses on developing and commercializing treatments for individuals living with kidney disease. Akebia Therapeutics is committed to improving the lives of people affected by kidney disease through the advancement of innovative therapies. For more information about Akebia Therapeutics and its work, please visit akebia.com/.

Akebia Therapeutics is a fully integrated biopharmaceutical company. Founded in 2007, the company focuses on developing and commercializing unique therapeutics for people with kidney disease. Akebia is headquartered in Cambridge, Massachusetts. The company has two FDA-approved products and a robust development organization. Akebia Therapeutics operates within the healthcare, pharmaceuticals, and biotechnology industries. The company's address is 245 First Street, Suite 1400, Cambridge, MA 02142. Akebia Therapeutics has two FDA-approved products. The company's competitive advantages include an experienced nephrology-focused commercial team, a robust development organization, and deep roots in the renal community. Akebia Therapeutics' target industries include healthcare, pharmaceuticals, and biotechnology. The company's leadership team includes John Butler, President and Chief Executive Officer; Steven K. Burke, M.D., Senior Vice President, Research & Development and Chief Medical Officer; Erik Ostrowski, Senior Vice President, Chief Financial Officer & Chief Business Officer; Nicole R. Hadas, Senior Vice President, Chief Legal Officer and Secretary; Nicholas Grund, Chief Commercial Officer; Meredith Bowman, Senior Vice President, People; Kimberly Garko, Senior Vice President, Quality; Carolyn M. Rucci, Senior Vice President, Legal and General Counsel; Bennett Smith, Senior Vice President, Commercial; and Tracey Vetterick, Vice President, Portfolio Strategy & Corporate Administration. Akebia Therapeutics is committed to innovation and collaboration within the renal community. The company's values and culture are described as bold and optimistic, challenging the status quo, emphasizing collaboration, innovation, and tenacity. Contact information for Akebia Therapeutics includes the phone number +1 617.871.2098 and several email addresses: [email protected], [email protected], [email protected], and [email protected].